The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world clinical outcomes of pazopanib immediately following immunotherapy discontinuation for the treatment of advanced renal cell carcinoma.
 
Xiting Cao
Employment - Novartis
Stock and Other Ownership Interests - Merck; Novartis
 
Derek Tang
Employment - Amgen; Novartis
Stock and Other Ownership Interests - Amarin Corporation; Amgen; Cara Therapeutics; Google; Novartis; Oncothyreon
 
Barbara Elizabeth Ratto
Employment - Novartis; Novartis (I)
Stock and Other Ownership Interests - Novartis
Honoraria - Novartis
Research Funding - Novartis; Novartis (I); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Austin Poole
Employment - Rocky Mountain Cancer Centers
Consulting or Advisory Role - Novartis
Research Funding - Novartis
 
Shoba Ravichandran
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Lixian Jin
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Wei Gao
Research Funding - Analysis Group
 
Elyse Swallow
Research Funding - Analysis Group
 
Nicholas J. Vogelzang
Employment - US Oncology
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Pfizer; UpToDate
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Caris Life Sciences; Fujifilm; Genentech/Roche; HERON; Pfizer; Tolero Pharmaceuticals
Speakers' Bureau - AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Exelixis; Genentech/Roche; Sanofi
Research Funding - Endocyte (Inst); Merck (Inst); Suzhou Kintor Pharmaceuticals (Inst); US Oncology (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bayer/Onyx; Exelixis; Genentech/Roche; Pfizer; US Oncology